SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BriaCell Announces ESMO 2026 Poster on Breast Cancer Biomarker

BriaCell says a poster at ESMO 2026 will highlight a circulating immune biomarker associated with clinical outcomes in metastatic breast cancer.

BCT

Related stories